--- SMARTEST Trial---
Condition: Mesothelioma, Malignant Interventions: Drug: Cyclophosphamide; Drug: Tremelimumab; Drug: Durvalumab Sponsors: University Health Network, Toronto; OICR Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials